Investigation notice: the schall law firm encourages investors in intra-cellular therapies, inc. with losses to contact the firm

Los angeles, california--(newsfile corp. - june 24, 2022) - the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of intra-cellular therapies, inc. ("intra-cellular" or "the company") (nasdaq: itci) for violations of the securities laws.the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.if you are a shareholder who suffered a loss, click here to...
ITCI Ratings Summary
ITCI Quant Ranking